Background: Making the decision to use complementary and alternative medicine (CAM) for cancer treatment is difficult in light of the limited available evidence for these treatments. It is unclear how patients use evidence to make these decisions. Objectives: (1) Describe the type of information about CAM that cancer patients use in their decision making;
Complementary and alternative medicine (CAM) consists of a group of diverse medical and health care systems, practices, and products that are not considered to be part of conventional biomedical practice but are used in conjunction with (complementary) or instead of (alternative) biomedical interventions. 1 Leis et al 2 found that overall, 43% of cancer patients in Canada used 1 or more CAM therapies. Common reasons for CAM use include improving health and well-being, strengthening the immune system, easing side effects of conventional cancer treatments, relieving cancer symptoms, finding a cure, and feeling in control of cancer management. 2, 3 Gaining or regaining control during experiences of uncertainty associated with serious illnesses such as cancer has been identified as an important factor in patient decision making, in particular with respect to CAM use. 4, 5 Several studies have examined how cancer patients make CAM treatment choices. 6, 7 Studies suggest that cancer patients have many information needs and use different types of information from a variety of sources to inform their decision making. A recent pilot study by Balneaves et al 8 identified that breast and prostate cancer patients' main information needs included both efficacy and safety of the treatment. Similarly, Boon et al 6 found that breast cancer patients identified a lack of meaningful information about efficacy and safety, highlighting the limited scientific evidence to support the available CAM options.
Although searching for information is an important step in patients' decision to use CAM, it is unclear whether and how patients are using the available evidence to guide their decision making. Studies on treatment decision making have found that cancer patients tend to approach these complex treatment decisions in very individualized, personal ways, because each patient perceives the risks and effectiveness of treatment options differently. Perceived treatment effects are often rooted in individual values, beliefs, and expectations, 9 and patients often make decisions based on limited, anecdotal information. 10, 11 For example, a recent study indicated that 65% of patients with inflammatory bowel disease would continue to use CAM even if a scientific study reported that one of the therapies they were using did not work. 12 Therefore, it is not surprising that clinicians fear that patients are using CAM without being informed of its risks and effectiveness. 13 Given the increase in CAM use and the explosion of available information about CAM, it is important from the perspective of health care providers that patients choose treatments for which there is at least some evidence of safety and efficacy. However, evidence is a term that has several meanings and can be located in different sources. Most researchers and many practitioners would acknowledge that evidence is based on the findings of scientific research. Evidence-based medicine (EBM) is defined as the conscientious, explicit, and judicious use of the current best evidence in making decisions about the care of individual patients. 14 One of the key ideas of EBM is a "hierarchy of levels of evidence," according to which randomized controlled trials (RCTs) and meta-analyses of RCTs are assumed to provide the most reliable evidence on the efficacy of medical interventions. 15 Nonrandomized trials (such as cohort and casecontrol studies) followed by case series, surveys, qualitative research, and anecdotes are considered to be lower quality in the evidence hierarchy. 16, 17 However, patients interested in CAM often seek information from multiple sources and often believe that nonresearch-based information provides proof equivalent in value to that of scientific evidence. This complicates the decision-making process because patients may be uncertain about which information to follow. This issue calls into question how patients in this situation find their way and what they think evidence is. Hence, the objectives of our study are to (1) describe the type of information about CAM that cancer patients use in their decision making, (2) understand why certain types of information about CAM are accepted as evidence by cancer patients, and (3) explore the role of scientific evidence in treatment decision making.
Methods
Because of the limited amount of information in this field and the exploratory nature of the study objectives, a qualitative research approach was used. Potential participants were informed of the study by word of mouth and through advertisements placed at a palliative care facility, a conventional cancer treatment center, and 2 integrative care centers that combine conventional and CAM practices located in Edmonton, Calgary, and Vancouver (Canada). Purposive sampling was used to recruit an equal number of participants (6 or 7) who were selected from each of the 4 different sites. Participants were considered to be CAM users if they reported using at least 2 different CAM treatments at the time of the interview. Each individual participated in an in-depth, semistructured interview, approximately 1 to 1.5 hours in length. Nondirective prompts were used to encourage discussion of important issues that arose. Prior to the interview, participants provided information on age, gender, education, previous CAM use, and type and stage of cancer. A series of questions (Table 1) guided the interviews, which were audiotaped and transcribed verbatim for subsequent analysis. Data collection and analysis were iterative, meaning that each transcript was analyzed before a subsequent interview took place, which helped to assess when data saturation was reached. 18 Two investigators (AM and MV) independently coded each transcript using basic content analysis. 19 Transcripts were first analyzed line by line to identify concepts, and then themes and categories were developed into a coding framework for application to the data. During this process, new themes developed and others changed. The software program NVIVO was used to assist data analysis. This study was approved by the Conjoint Health Research Ethics Board at the University of Calgary, the Health Research Ethics Board at the University of Alberta, and the Behavioral Research Ethics Board at the University of British Columbia.
Results
Twenty-seven patients were recruited who varied widely in terms of sociodemographic and disease characteristics (see Table 2 ). Twenty-three participants had tried CAM before, and 21 were currently using CAM. Four of the participants had exclusively used CAM since the beginning of their illness trajectory. Table 3 identifies the types of information about CAM that participants used. When participants were asked to define in their own words what evidence is, responses were fairly congruent. Most participants regarded evidence as proof and consisting of information that was often used as the basis for important treatment decisions. Participants used words such as proof, truth, argument, rationale, logic, and validation to describe evidence. Although participants appeared to agree on the need for evidence, what actually constituted high-quality information or evidence to them varied enormously.
Both past experience with CAM and the degree of illness severity guided participants' preferences for certain types of information. Information seeking and interpretation were constantly evolving processes: as participants learned more about CAM, their illness, and how they reacted to various CAM therapies, the more sophisticated their information seeking became. They were constantly growing and learning and changing. As a result, the value individuals placed on different types of CAM information and its subsequent use varied among study participants. Three groups with distinct ways of identifying CAM emerged from the data: new CAM users, experienced CAM users, and users with late-stage cancer. For each group we describe the role of CAM information seeking and evidence.
New CAM Users
Participants in this group (n = 10) had very little, if any, experience using CAM and were pragmatic in their reasons for exploring CAM. They were mainly using CAM to address the side effects of conventional treatments and to improve their quality of life. Individuals in this group felt overwhelmed by the amount of CAMrelated information available to them and were looking for information pertaining to the proposed benefits and financial costs of CAM treatments. Participants in this group frequently expressed concern with safety issues such as side effects or contraindications.
As participants began to learn about CAM, they started to recognize a difference between looking for information relating to conventional therapies and looking for information relating to CAM therapies. To many participants, looking for information about CAM therapies required a "more involved" process:
You get more of the aunt from Winnemucca, the hearsay story. Which is well and fine but if you are looking for hard substantiated facts, that is a little difficult, so then you have to do more research stuff and you have to take that information with a grain of salt. Have you ever thought about trying a particular therapy and decided not to? What was that related to? 5. How did you find out about the CAM therapies you are (or considered) using? 6. Which of these types of information do you like best? 7. What kind of information were you looking for? 8. Did you find as much information as you needed to decide whether to use the CAM therapy? 9. What convinces you to try a therapy? 10. How did you decide which information was useful? 11. How would you describe quality of information? 12. What information, if any, did you come across to support using the two most important therapies to you? 13. How do you know when information is truthful? 14. How did you deal with conflicting information about CAM therapies? 15. What were the most important factors that affected your decision to use or not use CAM? There are lots of studies out there with herbal stuff, but there is more homework for the CAM side.
Types of information used. CAM was typically introduced to participants while they were doing their own personal research via the Internet, newspapers, friends, family, and support groups. Although it was important for this group "to get all of the facts," the types of information that were most highly regarded and on which treatment decisions were mainly based were expert opinions from a physician or pharmacist and anecdotal information from friends and family. Participants especially appreciated learning about different therapies from other CAM users. Trust in one's physician was common across this group because their opinions weighed heavily in participants' decisionmaking process. After learning about a new therapy, participants would often turn to their physicians for further information and verification.
Once a decision was made and participants tried the CAM therapy in question, they proceeded to assess the outcomes of their treatment decision by continuously appraising changes in their quality of life, well-being, and symptoms. Factors such as financial cost and amount of time involved with the therapy were also considered.
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Type
Description Example
Anecdotal
Learning about the CAM experiences of another "I just kind of figured it would work well because it was person in a similar situation to him or her. a suggestion that I had heard from so many other people. A description of a specific example. Living proof.
A woman that I used to work with in the dry cleaners, she ended up getting cancer as well and she told me that her doctor and everyone had suggested the pot and that it really helped her through it." 2. Expert Advice and insight from conventional health care "I find that the pharmacist is an excellent source of information opinion practitioners, including physician, nurse, about CAM and they don't hesitate one minute, when they and pharmacist.
don't know the answer, they will go and look it up. They know." 3. Gut feeling Following one's intuition. a few magazines that I have been using for information on Literature rarely cites sources. Information CAM. I do trust publications like this. It is what is deemed published is often second-or third-hand trusted information." information. Short articles, written in simple language.
Scientific
Peer-reviewed journals and scientific reports. "I will go to the library at the university and I will do searches evidence Reference to empirical analysis or to results in the medical journals for scientific trials with PC SPEC of scientific experiments or investigations.
or Saw Palmetto. You know with research that is done in an academic lab, that there is some degree of rigor to it. It is | good reliable information." 6. Testimonials Advertising messages that reflect opinions, beliefs, "I saw a commercial on the TV a couple of weeks ago where findings, or experiences of a person other they had people singing the praises of this beverage which than the sponsoring advertiser. The messages gets rid of any cancer and arthritis you might have. So are often vague statements or exaggerated I thought, what the heck and ordered a bottle." claims by endorsers who are not easily identifiable.
Trial and
Trying a therapy and then observing the body for "After I started CAM, it was just trial and error. If it doesn't error any physiological response. If it produces work, don't do it. If it works, keep doing it, right? For taking desired effect, will continue; if not, will the pills to help me sleep or for the pot smoking and to have discontinue. Some indicators that prove the your body feel better, the pot was a lot better than the pills. therapy is working include decreased So benefit-wise, it makes my body feel a lot better, helps me symptoms, pain, and nausea; increased sleep at night, stops the night sweats, stops the aches and energy levels; and an improved state of mind.
pains, get a lot of back pain, just stuck at that and that aches and pains are not nice." a The types of information are not listed in any particular order.
enough to convince participants in this group to try a therapy. The prominent role that physicians play is reflected in the process participants described going through when making conventional treatment decisions: Participants tended to perceive information to be valid if it came from or was verified by a credible source and was consistent with what they believed to be true or had heard previously. Because they did not have prior experience with CAM, anecdotal information was valued when it came from sources that others with cancer deemed trustworthy and reliable. This type of information took the guesswork out of their decision making and provided participants with an idea of what to anticipate. Recognition that others are in a similar situation influenced perceptions of credibility:
I like finding out what other women are doing to fight their breast cancer. They have all been faced with the same trials and tribulations as I have. They have tried the same therapies I have considered trying and can tell me what it was like for them using them. That is firsthand knowledge I can put to use. I would trust information that came from people I know who have breast cancer. . . . I feel that they have done more research and have a better handle on good health than the average person has. They have the same attitude towards it that I have and therefore I trust how they are dealing with it and how they are getting their information.
To be assured of making the right decision, participants were looking for convergence of information with respect to a specific CAM therapy. If there was agreement between sources and information was communicated repeatedly and substantiated by a variety of sources, participants in this group began to consider this information as being sufficiently verified:
When you read article after article and it mentions the same kinds of things and keeps telling you that this type of thing helps this. And it's not the same person that's spelling this off every time but it comes from all different articles and you keep reading the same things, it starts to make some sense. I also like to talk to people and get a feel for them and listen to what they'd recommend. If it rang true with what I had been reading and what I thought, then I would take that as valuable information that I would use.
Role of scientific evidence. Although many participants explored scientific evidence behind the CAM products and services they were interested in trying, the advice of their physicians and the experience of family, friends, and acquaintances had a far greater impact on their decision.
Experienced CAM Users
Several patterns in the data suggest that the value participants placed on specific types of information differed with the degree of experience they had in assessing CAM-related information and using CAM therapies. For this group, the information-seeking process was more focused and less overwhelming. Individuals in this group (n = 12) had used CAM therapies either exclusively or in conjunction with conventional medicine for at least 6 months. For the experienced users in this study, CAM was an integral part of their wellness regime. They were experienced CAM users who were generally more geared toward holistic therapies that focused on mind-body versus a single herb or a massage.
Several participants felt "transformed" by CAM therapies and deeply believed in their effectiveness. On the whole, participants were using CAM for different reasons than new CAM users. Although some participants in this group were using CAM to "eradicate the cancer," this group was also attracted to CAM for its philosophical qualities-in particular, the appeal of holistic healing and the mind-body connection. Participants in this group preferred to take a more active and personal role in assessing CAM options, and although they were still concerned about the effectiveness of a therapy, they also wanted information about the philosophy behind it.
Types of information used. Participants generally placed little value on scientific evidence and had a more skeptical view of conventional medicine and research than did new users. Experienced CAM users held a different notion of what credible information is. Rather than placing value on information provided by health care providers or scientific evidence, members of this group preferred to make their decisions based on personal experience, which they saw as a way of verifying the validity of information about CAM.
Although popular media and information from friends and family were not completely ignored, typically these sources were not perceived as strong types of information. This group did not defer their final decision to an outside source of information as did the new CAM users. Several participants who had been using CAM for a long time identified their ultimate information source as their "gut instinct." They preferred to rely on this "gut sense" to confirm that a treatment was the right one for them. Participants in this group believed that this type of internal knowledge or evidence came with time, experience, and self-confidence. In this case, participants' bodies were the basis for knowledge development. Developing this internal evidence allows participants to resource themselves from the inside-out rather than having to rely solely on external information sources.
Everybody has different ideas for the best treatment. I listen to my body, my body tells me what it needs to do, if it says go to bed I go to bed. I don't argue with it, you've got to trust your body, your instincts. You have to become your own doctor, to educate and listen to yourself. Take all of the ideas that strike you with being true and put it in your plan. I don't follow the advice of anyone.
As participants had more hands-on experiences with CAM therapies, the types of information they used to support their choices shifted to those based largely on personal experience and gut feeling and through trial and error: I don't think it is so much information as it is experience. It's going through it and your own subjective personal response to what it was that you had experienced and saying, "Yeah, I feel good" or "this manages to give me control." Criteria for evidence. Several participants stated that they did not need to have specific proof of how effective a CAM therapy was in order to try it. Rather, it was whether the philosophy behind the therapy resonated with their personal belief system. Additionally, information about CAM therapies had to exhibit some congruence with what participants already believed to be true within their existing knowledge framework. Therapies had to logically fit and information had to make sense given participants' own values and life view:
It is very personal, I had read a book called The Healing Powers of Heat and Light and on the front of this cover was a picture of a biophoton. It was shining like a little white cross in the cell and because I am a Christian it said to me "this is the Christ life within me and this is our energy, this is how to harness all our energy." So that was personal for me. That was evidence enough.
Another participant, who was a firm believer in the practice of Traditional Chinese Medicine (TCM) held the information he received from his TCM practitioner about the effectiveness of various Chinese herbs in high esteem because he shared a similar outlook on lifestyle, health, and healing with the practitioner: Several years back, my TCM doctor prescribed PC-SPES for my prostate. I had never heard of it before but he said it had been proven to lower PSA and inhibit cancer growth when integrated into TCM practice like I was doing-acupuncture, diet, herbs. I took the PC-SPES mostly because I understood where he was coming from; his outlook on healing was the same as mine and therefore how he interpreted the effectiveness of the PC-SPES.
Members of this group shared several characteristics. Nine had poor experiences in the past with the conventional medical system that had left them with feelings of skepticism toward conventional care. All of these participants had very positive experiences with CAM therapies in the past. A few participants were trained as CAM practitioners, and the majority of participants shared the same outlook and philosophy on wellness and healing. Having used CAM over the years, this group had developed a fair amount of body awareness, which gave them a keen sense of what their body needed and if a particular treatment was working.
Similar to participants in the first group, these individuals validated their decision to try a CAM therapy by evaluating the perceived effectiveness of the treatment (ie, improved emotional well-being, decrease in symptoms) with factors like cost and the level of commitment required. In many instances, participants believed that through trial and error not only did they learn about CAM therapies but they were also able to recognize how their body responded to these therapies, the type of practitioner, and the style of practice: I guess you learn to discern better as you experience things. You know what works for your body and what doesn't work for your body. And so your pursuits are more structured that way.
Role of scientific evidence. This group was largely skeptical of scientific reports. They perceived articles in academic journals to cater to a medical audience and found them difficult to apply to their personal situation. Furthermore, scientific reports were seen to be difficult to interpret, and participants observed that findings were rarely replicated in similar studies: There's been 3 studies done in 3 different parts of the world with different findings and then 5 years down the line somebody refutes all that. Then we've got all this evidence so I always question it.
Additionally, several participants expressed concern that a prejudice exists in conventional medicine with respect to CAM that could potentially skew research findings.
Users With Late-Stage Cancer
Faced with an unfavorable prognosis, participants in this group, who were all hospitalized in a palliative care facility, felt overwhelmed with despair and hopelessness. Although some had prior experience using CAM, others did not. This, however, did not influence the type of information they valued in their decision to try a therapy. CAM use in this group (n = 5) was explained as a strategy to maintain hope, gain some control, and extend their lives. They were more willing than others to experiment with CAM therapies regardless of the available information.
Although information on the cost and ease of use was of interest, members of this group were mostly interested in the "success rate" of the treatment. Information needs were different than the other groups largely because of their sense of desperation and lack of time, both of which influenced the ways in which these individuals evaluated information.
Types of information used. Participants in this group found information conveyed to them through magazines, television, or pamphlets in a waiting room to be very valuable. Several participants referred to testimonials they had watched on television or articles they had read prior to hospitalization where the individuals featured in them had overcome their illness:
The interview with the doctor was pretty compelling. He was the head doctor of the college and he took ill at home and he struggled for a year. . . . He had all kinds of problems, he was constantly in pain. Barely able to function, he couldn't be left alone. There was little hope. He was in really rough shape. He starting taking these glyconutrients and started taking some pretty small dosages of it. And basically turned his life around and his functioning is quite normal, so it's a cool story.
When participants were prompted to elaborate on the type of information that would convince them to try a therapy, one participant stated: I am looking for a cure. I just want to hear how well it works and the success rate. This would fit with what evidence is. Evidence to me is the proof. There is a truth to the information. . . . If the person down the street drank this tea and is cured, then that is all I need.
Criteria for evidence. Information was regarded as being of good quality if participants recognized similarities to their own health concerns. This was especially true with the testimonial type information: I went for acupuncture too. I just picked the seniors' flyer up and leafed through it one day, "this looks interesting. I'm going to give it a try." This doctor whoever, he does acupuncture, can fix anything, for this, that, whatever and everything. We went to him and blew some money. It was all a gimmick. I was so desperate, I'd have tried anything, anything was worth a try at that point.
For some, an advertisement in a magazine giving them a glimmer of hope or an infomercial on television suggesting the possibility of a cure was often all it took to convince the participants to try the therapy.
Role of scientific evidence. These participants disagreed about the value of scientific evidence. Some participants acknowledged the value and importance, whereas others were more skeptical, explaining that the scientists behind the trials do not understand the philosophy behind many of the CAM therapies, so how could they conduct accurate research on it? Regardless of this, participants in this group were willing to try anything that sounded promising, and any risks associated with trying a therapy were typically not a factor in their decision to try a CAM therapy.
Discussion
Although this is a relatively small qualitative study, the results suggest that assessing CAM information is a complex, personal process for participants. What information patients accept as evidence depends on the context: their personal situation, the disease process, and their underlying values and beliefs. What information patients accept as evidence to make treatment decisions depends on how much experience they have with CAM and on the stage of their disease.
For participants who were new to CAM, the value and trust they placed on information received from friends and conventional health care providers were defining characteristics when making CAM-related decisions. Physicians and other conventional health care providers were considered an authority regarding CAM information. This group's need to verify CAM information with a physician suggests that they were uncomfortable with the uncertainty of nonmedical or nonscientific information sources and required reassurance regarding safety and effectiveness from an established health authority figure. Furthermore, these patients relied on external sources of knowledge that were consistent and came from a credible source.
This was in stark contrast to the more experienced group of CAM users, who did not assign any special evidential authority to physicians or other health care providers and were skeptical of scientific results. Rather, they gravitated more toward experientially based evidence, such as anecdotes, personal experience, and intuition. Hence, for experienced users, an internal rather than an external source of knowledge was used as an information resource to make decisions regarding their choice of CAM use. These participants were also the ones to make the final decision regarding treatment. Most notably, these participants differed from other users in their sense of confidence in and control over their treatment choices.
Individuals with late-stage cancer were most likely to try any CAM therapy regardless of the information or evidence. Feelings of desperation appeared to lead to a less systematic approach to finding out about CAM therapies and, correspondingly, overall CAM information needs were much less distinct than those of other participants. This is consistent with past studies that have linked information needs to disease severity. 20 Information needs may also be related to factors such as time, lack of energy, the level of distress, hopelessness or depression, and access to information.
What becomes evident is a logical pattern of the types (and sources) of information patients seek out to make decisions regarding CAM in the treatment and management of cancer. More important, what constitutes reliable information or evidence is different for each of the 3 patient groups and is also quite different from the concept of evidence as espoused by evidence-based medicine (EBM).
The meaning of scientific evidence is by no means simple or straightforward. Although Sackett's definition of evidence as only that which is based on scientific research is still commonly used, in 2000 Sackett et al 21 defined the practice of EBM as the integration of 3 key elements: best available evidence from systematic research, clinical expertise, and patient values. In this context, patients, ideally, make treatment decisions that are informed by evidence; meet their values, beliefs, and expectations; and are supported by physicians' clinical judgment. For many patients, individual authority and the lived experience 22 emerged as valuable information sources equal to science-based evidence. This reliance on nonauthoritative or first-person evidence 23 reflects a broader social trend, where society's faith in the ability of science and technology to solve health-related problems and authoritative knowledge to provide answers is declining.
The issue of what question drives the search for CAM information is an important one. Personal experience, expert opinion, and anecdotal information were often used to illuminate an aspect of CAM therapies that the RCT, the gold standard of EBM, could not. In 2001, Jonas 24 identified that evidence comes in a variety of forms and purposes, satisfying the specific information needs of various stakeholders involved in the health care system. He also recognized that information that may be good for one purpose may not necessarily work well or be suitable for another. Hence, the interpretation of various forms of information as evidence and how it is valued and used by a practitioner and a patient in making health care decisions could be very different: Conventional practitioners, trained to function and make decisions within an EBM model or framework, look at associations between benefits and treatments and, thus, value observational and RCTbased research as an evidence base. Participants in this study, however, generally placed more value on their first-person experience. Although this perspective is low or nonexistent within the EBM hierarchy of evidence, it is important to consider this perspective, given the increasing impact of patients' preferences, concerns, and expectations on clinical decision making. Practitioners need to be aware of patients' information-seeking patterns, in order to protect them from harm and at the same time consider information that the patient values as evidence, because it will affect the patient-provider relationship, patient compliance, and the overall outcomes of the treatment plan.
Perhaps a solution to these fundamentally different ways of thinking lies in the concept of an "evidence house," as proposed by Jonas, 24 where different types of information and purposes are equally recognized but are "housed" in different rooms. Jonas argued that because different types of questions are best answered by different types of evidence, one room could be for RCTs and systematic reviews, another for qualitative case reports, another for epidemiological outcomes, and so on.
In this context it is also important to consider another problematic aspect of an evidence hierarchy. A hierarchy postulates that of all the designs, the RCT is best suited to determine whether an intervention causes the desired result. This is true for determining efficacy and maximizing internal validity; however, it is not always recognized that the other designs in the hierarchy should not be evaluated in terms of failing to answer a research question for which they are not suitable and are not intended. For example, qualitative research was never intended to assess the efficacy of an intervention; however, it is very suitable to address patients' personal perceptions of what is affecting their health and well-being.
Previous studies [25] [26] [27] [28] have identified the need for more appropriate, clear, succinct, relevant, and easy to understand information that addresses (1) the unique nature of individual cases to assist cancer patients in making informed treatment choices, (2) factors that affect such choices, and (3) ways to discuss CAM use with patients. The results of the current study suggest that in addition, academics, educators, and practitioners need to join efforts to provide information on CAM that combines scientific evidence and individual experiences targeted at different patient groups. Using individual experiences and evidence-based case studies may enhance CAM users' trust in the outcomes of EBM and foster increased use of empirically supported CAM treatments. This idea transfers well to the field of CAM, where one of the guiding principles is to embrace the patient's role in the decision-making process. If we take patient care seriously, the best evidence will vary depending on the values of the patient and nature and context of the disease.
